Molecular Testing in Thyroid Cancer
0 Bekeken
• 07/01/23
0
0
insluiten
administrator
abonnees
Panelists R. Michael Tuttle, MD; Eric J. Sherman, MD; Marcia S. Brose, MD, PhD; Naifa Busaidy, MD, FAPC, FACE; and Frank Worden, MD, discuss the present day use of molecular testing for thyroid cancer, which, for now, is largely prognostic but not predictive.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties